Endophthalmitis due to Trichosporon beigelii in acute leukemia

International Journal of Hematology

Volumn 85, Issue 5, 2007, Pages 415-417

  Hara, Satoshi ^a   Yokote, Taiji ^a   Oka, Satoko ^a   Akioka, Toshikazu ^a   Kobayashi, Kichinosuke ^a   Hirata, Yuji ^a   Miyoshi, Takuji ^a   Tsuji, Motomu ^a   Hanafusa, Toshiaki ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Amphotericin B (AMPH B); Endophthalmitis; Trichosporon beigelii

Indexed keywords

AMPHOTERICIN B; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; METHOTREXATE; MITOXANTRONE; VINCRISTINE; VORICONAZOLE; ANTIFUNGAL AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BLOOD CULTURE; BLURRED VISION; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHORIORETINITIS; ENDOPHTHALMITIS; FEMALE; HUMAN; LEUKOPENIA; MALE; MYCOSIS; TRICHOSPORON BEIGELII; VITRECTOMY; ACUTE DISEASE; ACUTE LYMPHOCYTIC LEUKEMIA; ANTIBIOTIC RESISTANCE; MICROBIOLOGY; MIDDLE AGED; MYELOID LEUKEMIA; TRICHOSPORON;

ACUTE DISEASE; ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; DRUG RESISTANCE, FUNGAL; ENDOPHTHALMITIS; FEMALE; FLUCONAZOLE; FLUCYTOSINE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MYCOSES; TRICHOSPORON;

EID: 34548425022     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.06228     Document Type: Article

References (30)

1. Ulfig K. The occurrence of keratinolytic fungi in the polluted environment of the Labedy District in Gliwice [in Polish]. Rocz Panstw Zakl Hig. 1994;45:337-346.
2. Sugita T, Nishikawa A, Ichikawa T, Ikeda R, Shinoda T. Isolation of Trichosporon asahii from environmental materials. Med Mycol. 2000;38:27-30.
3. Watson KC, Kallichurum S. Brain abscess due to Trichosporon cutaneum. J Med Microbiol. 1970;3:191-193.
4. Rivera R, Cangir A. Trichosporon sepsis and leukemia. Cancer. 1975;36:1106-1110.
5. Marier R, Zakhireh B, Downs J, Wynne B, Hammond GL, Andriole VT. Trichosporon cutaneum endocarditis. Scand J Infect Dis. 1978;10:255-256.
6. Evans HL, Kletzel M, Lawson RD, Frankel LS, Hopfer RL. Systemic mycosis due to Trichosporon cutaneum: a report of two additional cases. Cancer. 1980;45:367-371.
7. Yung CW, Hanauer SB, Fretzin D, Rippon JW, Shapiro C, Gonzalez M. Disseminated Trichosporon beigelii (cutaneum). Cancer. 1981;48:2107-2111.
8. Walsh TJ, Newman KR, Moody M, Wharton RC, Wade JC. Trichosporonosis in patients with neoplastic disease. Medicine (Baltimore). 1986;65:268-279.
9. Walsh TJ. Trichosporonosis. Infect Dis Clin North Am. 1989;3:43-51.
10. Gueho E, Improvisi L, de Hoog GS, Dupont B. Trichosporon on humans: a practical account. Mycoses. 1994;37:3-10.
11. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103:620-625.
12. Amadori S, Arcese W, Isacchi G, et al. Mitoxantrone, etoposide, and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemia. J Clin Oncol. 1991;9:1210-1214.
13. Mori T, Ikemoto H, Matsumura M, et al. Evaluation of plasma (1→3)-β-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections. Eur J Clin Chem Clin Biochem. 1997;35:553-560.
14. Miyazaki T, Kohno S, Mitsutake K, Maesaki S, Tanaka K, Hara K. (1→3)-β-D-glucan in culture fluid of fungi activates factor G, a limulus coagulation factor. J Clin Lab Anal. 1995;9:334-339.
15. Thomas DA, O'Brien S, Cortes J, et al. Outcome with the Hyper-CVAD regimens in lymphoblastic leukemia. Blood. 2004;104:1624-1630.
16. Anaissie EJ, Bodey GP, Kantarjian H, et al. New spectrum of fungal infections in patients with cancer. Rev Infect Dis. 1989;11:369-378.
17. Groll AH, Walsh TJ. Uncommon opportunistic fungi: new nosocomial threats. Clin Microbiol Infect. 2001;7:8-24.
18. Sheikh HA, Mahgoub S, Badi K. Postoperative endophthalmitis due to Trichosporon cutaneum. Br J Ophthalmol. 1974;58:591-594.
19. Walsh TJ, Orth DH, Shapiro CM, Levine RA, Keller JL. Metastatic fungal chorioretinitis developing during Trichosporon sepsis. Ophthalmology. 1982;89:152-156.
20. Walsh TJ, Melcher GP, Lee JW, Pizzo PA. Infections due to Trichosporon species: new concepts in mycology, pathogenesis, diagnosis and treatment. Curr Top Med Mycol. 1993;5:79-113.
21. Anaissie E, Gokaslan A, Hachem R, et al. Azole therapy for trichosporonosis: clinical valuation of eight patients, experimental therapy for murine infection, and review. Clin Infect Dis. 1992;15:781-787.
22. Bodey GP. Azole antifungal agents. Clin Infect Dis. 1992;14(suppl 1):S161-S169.
23. Kamberi P, Hashimoto A, Tashiro T, Nasu M. Efficacy of amphotericin B and azoles alone and in combination against disseminated trichosporonosis in neutropenic mice. Chemotherapy. 1998;44:55-62.
24. Spirn MJ, Roth DB, Yarian DL, Green SN. Postoperative fungal endophthalmitis caused by Trichosporon beigelii resistant to amphotericin B. Retina. 2003;23:404-405.
25. Tawara S, Ikeda F, Maki K, et al. In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi. Antimicrob Agents Chemother. 2000;44:57-62.
26. Espinel-Ingroff A. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743, 872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol. 1998;36:2950-2956.
27. Petraitis V, Petraitiene R, Groll AH, et al. Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits. Antimicrob Agents Chemother. 2002;46:1857-1869.
28. Breit SM, Hariprasad SM, Mieler WF, Shah GK, Mills MD, Grand MG. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol. 2005;139:135-140.
29. Johnson LB, Kauffman CA. Voriconazole: a new triazole antifungal agent. Clin Infect Dis. 2003;36:630-637.
30. Walsh TJ, Finberg RW, Arndt C, et al, for the National Institute of Allergy and Infectious Diseases Mycoses Study Group. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. N Engl J Med. 1999;340:764-771.